Ansgar Santel

Chief Executive Officer & Head of Translational Research & Alliance Management Pantherna Therapeutics

Experienced Biomedical Scientist with over 20 years of industry experience in pharmaceutical research. Proficient in translational medicine, oncology, and molecular biology, with a specialization in nucleic acid therapeutics. Holds a PhD in Biology from Philipps-Universität Marburg and completed postdoctoral research at Stanford University.

Seminars

Wednesday 28th January 2026
Optimizing In Vivo Delivery & Dosing Strategies to Maximize mRNA Therapeutic Efficacy & Safety
2:00 pm
  • Comparing systemic vs local delivery strategies for achieving tissue-specific expression
  • Examining how lipid type, ionizable components, and dosing schedule impact safety and immunogenicity
  • Reviewing preclinical to clinical case studies where formulation or dosing adjustments significantly impacted trial outcomes
Ansgar Santel Speaker at 5th mRNA Based Therapeutics Summit Europe